Medical Wrap Up: Australia, Markets, Interview – GW Pharma

8 July 2018: Plenty of interesting things happening in the medical sphere and the injection of Canada into the fray has really upped the stakes. AUSTRALIA (i) University of Sydney – Pelican Study Cannabis & Epilepsy (ii) Medical Cannabis Favored to Treat MS Spasticity and Other Ills by Doctors in Australia, Survey Finds. MARKETS:  Medicinal Marijuana’s $500m Economic ‘Blow’ For The Bahamas. INTERVIEW – GW PHARMA: Justin Gover on marketing the first cannabis-based drug.


Go to Source

Powered by WPeMatico